Tokyo, Japan

Kimiko Sugita

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimiko Sugita. Retrieved from https://idiyas.com/inventor/kimiko-sugita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Kimiko Sugita

Introduction

Kimiko Sugita is a notable inventor based in Tokyo, Japan, recognized for her contributions to pharmaceutical innovations. With a total of two patents to her name, she has demonstrated a remarkable ability to develop advanced solutions in the field of medical science.

Latest Patents

Among her latest innovations, Sugita has developed a suppository that features a hydrophobic hydroxypropyl methylcellulose composition. This invention provides an effective suppository base with minimal interaction with drugs, ensuring excellent retainability, which is essential for patient care. Additionally, she has contributed to the creation of an antifungal agent, showcasing her diverse expertise in tackling various medical challenges.

Career Highlights

Kimiko works at Taisho Pharmaceutical Co., Ltd., where her research and innovative efforts are helping to shape the future of healthcare. Her work is highly regarded, having advanced therapeutic options available to patients.

Collaborations

Throughout her career, Sugita has collaborated with talented coworkers, including Toshi Akashi and Shigeo Tanaka. These partnerships foster a creative environment that thrives on innovation, leading to successful developments in their projects.

Conclusion

Kimiko Sugita exemplifies the spirit of innovation in the pharmaceutical industry. Her patents reflect a commitment to improving patient outcomes through thoughtful design and research, positioning her as a significant contributor to advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…